“Europe’s largest sperm-donor genetic scandal: nearly 200 children conceived with cancer-causing mutation linked to donor’s sperm”

A sweeping cross-border investigation has uncovered one of the most alarming genetic scandals in the history of assisted reproduction. At least 197 children across 14 European countries were conceived using sperm from a donor who unknowingly carried a rare but devastating TP53 mutation – the genetic defect associated with Li-Fraumeni syndrome, a disorder that confers up to a 90% lifetime risk of developing cancer.

The investigation, led by 14 public broadcasters including the BBC, reveals that for nearly 17 years the donor’s sperm was distributed to clinics throughout Europe, with the Danish-based European Sperm Bank supplying dozens of fertility centres. Although the donor passed all routine screening tests, he was later found to be a genetic mosaic: only some of his cells carried the harmful mutation, but up to 20% of his sperm did.

This silent flaw meant the mutation was not detectable at the time, yet any child conceived from an affected sperm cell inherited the variant in every cell of their body.

Doctors have already confirmed multiple cancer diagnoses among affected children. At least 10 children identified through early genetic screening developed tumours, some more than once. Several have died. The numbers are expected to rise.

Dr Edwige Kasper, a French cancer geneticist whose team helped uncover the pattern, described the findings as “devastating for families” and “deeply concerning for the integrity of fertility medicine”. She emphasized that the mutation triggers extremely high cancer risks, ranging from bone cancers and brain tumours to aggressive childhood leukaemias.

Because Li-Fraumeni syndrome is so severe, early and continuous medical surveillance – including yearly full-body MRIs – becomes essential. For many affected families, the psychological and medical burden will last a lifetime.

The European Sperm Bank, which has suspended the donor permanently, acknowledged that national limits on donor usage were violated in some countries. Belgium, for example, allows sperm from a single donor to be used for no more than six families. Instead, sperm from this donor was used by 38 Belgian women, resulting in 53 children.

While no UK clinic purchased the donor’s sperm directly, a small number of British families travelled to Denmark for treatment and used sperm from the donor. Those families have been informed following notification to the UK’s Human Fertilisation and Embryology Authority (HFEA).

The scandal highlights a glaring regulatory gap: there is no international law limiting the global number of births per donor. As fertility clinics increasingly rely on large commercial sperm banks supplying multiple countries, donor tracking becomes nearly impossible.

Experts warn that implementing stricter genetic screening could drastically reduce the number of available donors, worsening already acute shortages. “You simply cannot screen for everything,” said Prof Allan Pacey, reproductive medicine specialist. “But this case shows that international coordination is desperately needed.”

Beyond medical implications, the psychological toll is immense. Parents describe receiving the news about the mutation as “a bombshell” and “a life sentence we didn’t choose”. Many now live in perpetual uncertainty, monitoring their children closely for signs of early cancer.

Bioethicists argue that the case raises urgent questions about donor anonymity, global donor limits, responsibility of sperm banks, and the need for multinational registries. Calls are growing for Europe-wide rules restricting donor usage and mandating long-term tracking of genetic outcomes.

As the full scale of the incident comes to light, it stands as a stark warning: the rapid globalisation of sperm donation has outpaced the world’s ability to regulate it. For nearly 200 children – and their families – the consequences may last a lifetime.